Lupus & antiphospholipid syndrome

State of current management of the heightened risk for atherosclerotic cardiovascular events in an established cohort of patients with lupus erythematosus

Lupus Sci MedPublished Cohort study

Authors' conclusion

Patients with CLE-only or CLE+SLE are undertreated compared with the new guidelines and, accordingly, they experience a significant burden of ASCVD events.

Study context

Population
UPenn Longitudinal Lupus Cohort of patients with CLE, without or with concurrent SLE, with full access to medical recordsLE-ASCVD Study Cohort
Participants
370 participants
Exposure
CLE-only vs CLE+SLE
Outcome
Current cardiovascular management in light of new LE-specific ASCVD guidelines
Methodological detailssingle-centre longitudinal cohort
  • Single-centre longitudinal cohort

Main finding

As reported in the abstract

Cardiovascular risk management vs new guidelines
Designated primary-care physician
336 out of 370 (90.8%)
Most recent low-density lipoprotein (LDL) above goal
249 out of 370 (67.3%)
Hypertension
Two-hundred sixty-six (71.9%)
Hypertension undertreated or untreated
198 out of 266 (74.4%)
Current smokers without documented cessation counselling or referrals
51 out of 63 (81.0%)

Observational data: associations, not effects.

Further findings

Clinically meaningful discordance between 3 atherosclerotic cardiovascular disease (ASCVD) risk estimation methods (ACC-ASCVD Risk Estimator Plus, QRisk3, lupus erythematosus (LE) risk categories)

Patients qualifying for online estimators
278
Discordance
169 out of 278 (60.8%)

Documented ASCVD event rate · first 10 years after enrolment

ASCVD event rate
13.5% (95% CI 8.9%, 17.9%)
Similar between CLE-only and CLE+SLE
  • Average age at enrolment 47 years; preponderance of women

Original publication

State of current management of the heightened risk for atherosclerotic cardiovascular events in an established cohort of patients with lupus erythematosus. Lupus Sci Med. Published 21 August 2023. doi:10.1136/lupus-2023-000908

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.